Skip to main content
. 1998 Jul 1;188(1):39–48. doi: 10.1084/jem.188.1.39

Figure 3.

Figure 3

Effect of treatment with anti–TGF-β monoclonal antibody (given on days −1, 2, 5, and 7 after infection) on the course of malaria parasitemia (mean % parasitemia ± SD; a–c) and mouse survival (d–f) with (a and d) 105 P. berghei, (b and e) 105 P. chabaudi chabaudi, and (c and f) 105 P. yoelii. •, anti–TGF-β–treated; ○, control, treated with irrelevant IgG1.